Non-Enzymatic Glycation of Transferrin and Diabetes Mellitus
Yanqi Ma,Jing Cai,Ying Wang,Jingfang Liu,Songbo Fu
DOI: https://doi.org/10.2147/DMSO.S304796
2021-06-09
Abstract:Yanqi Ma, 1, * Jing Cai, 1, * Ying Wang, 1 Jingfang Liu, 1, 2 Songbo Fu 1, 2 1 The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China; 2 Department of Endocrinology,The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China *These authors contributed equally to this work Correspondence: Jingfang Liu Department of Endocrinology, The FirstHospital of Lanzhou University, 1 Donggang West Road, Lanzhou, Gansu, 730000, People's Republic of China Tel +86-931-8356242 Email Diabetes is a metabolic disease characterized by high blood sugar. Its complications may damage multiple organs, such as eyes, kidneys, heart, blood vessels, and nerves, severely threatening human health. Transferrin (Tf) is a major iron transport protein in the body. Recent studies have shown that the degree of non-enzymatic glycated modification of Tf is increased in diabetic patients, and glycated Tf is closely related to the occurrence and development of diabetes and diabetic complications. However, the molecular mechanisms underlying this glycated modification in diabetes and diabetic complications are still unclear. It is speculated that the mechanism may be that glycated modification reduces the binding ability of Tf and its receptor TfR, followed by excessive iron accumulation in the body. Iron overload in the body may further lead to the death of pancreatic beta cells and insulin resistance by increasing oxidative stress, inducing iron death, interfering with the insulin signaling pathway, and causing autophagy deficiency. In addition, non-enzymatic glycation affects the binding of Tf with chromium and reduces the ability of Tf to transport chromium into tissues, resulting in a decrease in the levels of chromium in tissues and ultimately affecting the sensitivity of tissues to insulin. In diabetic patients, the concentrations of glycated Tf in serum were significantly correlated with those of fructosamine.Tf has a shorter half-life, and not affected by anemia or hypoalbuminemia and less negative charge under physiological conditions, while glycated modification could not change the isoelectric point of Tf, which easily passes through the negatively charged basement membrane of the glomerulus. Therefore, compared to glucosamine, HbA1C, etc., glycated Tf may be a future biomarker for evaluating short-term glycemic control and early renal damage in diabetic patients. Keywords: transferrin, glycation, diabetes, diabetic complication Diabetes is a metabolic disease characterized by high blood sugar. The incidence of diabetes is increasing worldwide. The International Diabetes Federation estimated that the number of adults with diabetes was about 451 million in 2017 and that it would increase to 693 million in 2045. 1 Diabetic complications, such as nephropathy, retinopathy, atherosclerosis, and neuropathy, threaten human health severely. 2 Non-enzymatic glycation reaction, also known as "Maillard" reaction, is a spontaneous, cascading, non-enzymatic, site-specific complex reaction. 3 It is different from glycosylation (enzyme-mediated conjugation) that can site-specifically link the sugar at lower temperatures. This mild modification has been used to enhance the sugar-conjugation efficiency and improve the functional properties of proteins. 4 Non-enzymatic glycation of proteins sets the stage for the formation of advanced glycation end-products and the development of chronic complications of diabetes 5 Transferrin (Tf) is a critical iron transport protein in the body. 6 , 7 In recent years, with the continuous deepening of research technologies, such as proteomics and glycometabonomics, and the rapid development of related detection technologies, such as high-performance liquid chromatography/electrospray ionization-mass spectrometry (HPLC/ESI-MS), studies have shown that non-enzymatic glycated modification of Tf is closely related to the occurrence and development of diabetes. 8–12 In vitro, under high sugar state, Lys 206 and Lys 534 in the structure of apo-transferrin 9 or Lys103, Lys312, and Lys382 in the structure of holo-transferrin 10 are most sensitive to glycation modification. The specific glycation of these sites may affect the normal structure and function of Tf. Compared to non-diabetic patients, the degree of Tf glycation in the serum of diabetic patients was increased. <a -Abstract Truncated-
endocrinology & metabolism